Obstructive sleep apnea increases hemoglobin A1c levels regardless of glucose tolerance status

Sleep Medicine

Volumn 13, Issue 8, 2012, Pages 1050-1055

  Tamura, Akira ^a   Kawano, Yoshiyuki ^a   Watanabe, Toru ^b   Kadota, Junichi ^a  

^a OITA UNIVERSITY   (Japan)

^b Oita Nakamura Hospital   (Japan)

Author keywords

Apnea hypopnea index; Glucose tolerance; Hemoglobin A1c; Hypoxia; Obstructive sleep apnea; Polysomnography

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; OXYHEMOGLOBIN;

ADULT; AGE; APNEA HYPOPNEA INDEX; AROUSAL; ARTERIAL OXYHEMOGLOBIN SATURATION; ARTICLE; BLOOD GAS PARAMETERS; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME;

AGED; ANOXIA; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PREDIABETIC STATE; REGRESSION ANALYSIS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84865281664     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2012.04.007     Document Type: Article

References (36)

1. Strohl K.P., Novak R.D., Singer W., Cahan C., Boehm K.D., Denko C.W., et al. Insulin levels, blood pressure and sleep apnea. Sleep 1994, 17:614-618.
2. Grunstein R.R., Stenlof K., Hedner J., Sjöström L. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. Int J Obes Relat Metab Disord 1995, 19:410-418.
3. Stoohs R.A., Facchini F., Guilleminault C. Insulin resistance and sleep disordered breathing in healthy humans. Am J Respir Crit Care Med 1996, 154:170-174.
4. Strohl K.P. Diabetes and sleep apnea. Sleep 1996, 19(Suppl.10):S225-228.
5. Ip M.S., Lam K.S., Ho C., Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000, 118:580-586.
6. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Hopper K., Lotsikas A., Lin H.M., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000, 85:1151-1158.
7. Elmasry A., Lindberg E., Berne C., Gislason T., Awad Tageldin M., Boman G. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001, 249:153-161.
8. Ip M.S., Lam B., Ng M.M., Lam W.K., Tsang K.W., Lam K.S. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002, 165:670-676.
9. Punjabi N.M., Sorkin J.D., Katzel L.I., Goldberg A.P., Schwartz A.R., Smith P.L. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002, 165:677-682.
10. Punjabi N.M., Shahar E., Redline S., Gottlieb D.J., Givelber R. Sleep heart health study investigators. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004, 160:521-530.
11. Harsch I.A., Schahin S.P., Brückner K., Radespiel-Tröger M., Fuchs F.S., Hahn E.G., et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 2004, 71:252-259.
12. Meslier N., Gagnadoux F., Giraud P., Person C., Ouksel H., Urban T., et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 2003, 22:156-160.
13. Tamura A., Kawano Y., Watanabe T., Kadota J. Relationship between the severity of obstructive sleep apnea and impaired glucose metabolism in patients with obstructive sleep apnea. Respir Med 2008, 102:1412-1416.
14. Botros N., Concato J., Mohsenin V., Selim B., Doctor K., Yaggi H.K. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 2009, 122:1122-1127.
15. Muraki I., Tanigawa T., Yamagishi K., Sakurai S., Ohira T., Imano H., et al. CIRCS Investigators. Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS). Diabetologia 2010, 53:481-488.
16. Nathan D.M., Kuenen J., Borg R., Zheng H., Schoenfeld D. A1c-derived average glucose study group. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008, 31:1473-1478.
17. American diabetes association Standards of medical care in diabetes-2011. Diabetes Care 2011, 34(Suppl. 1):S11-S61.
18. Aronsohn R.S., Whitmore H., Van Cauter E., Tasali E. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 2010, 181:507-513.
19. Lam D.C., Lui M.M., Lam J.C., Ong L.H., Lam K.S., Ip M.S. Prevalence and recognition of obstructive sleep apnea in Chinese patients with type 2 diabetes mellitus. Chest 2010, 138:1101-1107.
20. Seino Y., Nanjo K., Tajima N., Kadowaki T., Kashiwagi A., Araki E., et al. The committee of the japan diabetes society on the diagnostic criteria of diabetes mellitus. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 2010, 1:212-228.
21. Iber C., Ancoli-Israel S., Chesson A.L., Quan S.F. The AASM manual for the scoring of sleep and associated events: rules, therminology and technical specifications 2007, American Academy of Sleep Medicine, Westchester, IL, [1-59].
22. 1c. Diabetes Care 2003, 26:881-885.
23. Babu A.R., Herdegen J., Fogelfeld L., Shott S., Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005, 165:447-452.
24. Dawson A., Abel S.L., Loving R.T., Dailey G., Shadan F.F., Cronin J.W., et al. CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med 2008, 15(4):538-542.
25. West S.D., Nicoll D.J., Wallace T.M., Matthews D.R., Stradling J.R. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007, 62:969-974.
26. Iiyori N., Alonso L.C., Li J., Sanders M.H., et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 2007, 175:851-857.
27. Zhan G., Serrano F., Fenik P., Hsu R., Kong L., Pratico D., et al. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 2005, 172:921-929.
28. Somers V.K., Dyken M.E., Clary M.P., Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995, 96:1897-1904.
29. Vgontzas A.N., Pejovic S., Zoumakis E., Lin H.M., Bentley C.M., Bixler E.O., et al. Hypothalamic-pituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. J Clin Endocrinol Metab 2007, 92:4199-4207.
30. Lavie L. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 2003, 7:35-51.
31. Khaw K.T., Wareham N., Luben R., Bingham S., Oakes S., Welch A., et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 2001, 322:15-18.
32. Selvin E., Coresh J., Golden S.H., Brancati F.L., Folsom A.R., Steffes M.W. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med 2005, 165:1910-1916.
33. Gerstein H.C., Pogue J., Mann J.F., Lonn E., Dagenais G.R., McQueen M. HOPE investigators. The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 2005, 48:1749-1755.
34. Selvin E., Steffes M.W., Zhu H., Matsushita K., Wagenknecht L., Pankow J., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010, 362:800-811.
35. Jørgensen L., Jenssen T., Joakimsen O., Heuch I., Ingebretsen O.C., Jacobsen B.K. Glycated hemoglobin level is strongly related to the prevalence of carotid artery plaques with high echogenicity in nondiabetic individuals: the Tromsø study. Circulation 2004, 110:466-470.
36. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.